Neuropace
NPCE
NPCE
25 hedge funds and large institutions have $176M invested in Neuropace in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.01% more ownership
Funds ownership: 68.88% → 69.89% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.74M | |
| 2 | +$4.14M | |
| 3 | +$1.38M | |
| 4 |
Morgan Stanley
New York
|
+$397K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$377K |
Top Sellers
| 1 | -$5.03M | |
| 2 | -$4.33M | |
| 3 | -$1.45K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$404 |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$88 |